scispace - formally typeset
D

Davide Festi

Researcher at University of Bologna

Publications -  247
Citations -  10674

Davide Festi is an academic researcher from University of Bologna. The author has contributed to research in topics: Cirrhosis & Chronic liver disease. The author has an hindex of 49, co-authored 236 publications receiving 9334 citations. Previous affiliations of Davide Festi include University of Chieti-Pescara & University of Messina.

Papers
More filters
Journal ArticleDOI

Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature

TL;DR: Serum markers, abdominal ultrasonography, and particularly liver and spleen stiffness measurement are critically evaluated, which represent the more promising methods to stage PH degree and to assess the presence/absence of esophageal varices (EV).
Journal ArticleDOI

Autoimmune liver diseases in a paediatric population with coeliac disease - a 10-year single-centre experience.

TL;DR: Gluten‐free diet (GFD) normalizes cryptogenic forms, but most likely not autoimmune hepatitis (AIH), for this condition, immunosuppressants represent the treatment.
Journal ArticleDOI

Development, validation, and application of a single-tube radioimmunoassay for cholic and chenodeoxycholic conjugated bile acids in human serum.

TL;DR: The assay was shown to be specific, sensitive, accurate, and precise when used for serum samples from subjects and patients with increased bile acid in the serum because of liver disease, and results correlate well with those by gas chromatography.
Journal ArticleDOI

Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study

TL;DR: LSM by TE can be considered a promising method to perform an early, preclinical diagnosis and follow-up of VOD/SOS, and Interestingly, LSM values did not increase significantly in patients experiencing hepatobiliary complications (according to the Common Terminology Criteria) other than VOD /SOS.